Pharmacists in Mc Kees Rocks, Pennsylvania


28 Pharmacists found in Mc Kees Rocks
female pharmacist

Mary Lynn Seiss


Pharmacist
1770 Pine Hollow Rd, Mc Kees Rocks, PA 15136
412-331-7080     412-331-7187

female pharmacist

Mary Ann Gilmore, RPH


Pharmacist
500 Pine Hollow Rd, Mc Kees Rocks, PA 15136
412-771-6366    

female pharmacist

Melinda Friday, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
27 Heckel Rd, Mc Kees Rocks, PA 15136
412-771-2149    



male pharmacist

Mohammad Rifai


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5703 Steubenville Pike, Mc Kees Rocks, PA 15136
412-788-4676    

female pharmacist

Mrs. Rachael Wachter, PHARMD


Pharmacist
1800 Mckees Rocks Rd, Mc Kees Rocks, PA 15136
412-771-8366     412-771-8757

female pharmacist

Rachel Triggs


Pharmacist
5703 Steubenville Pike, Mc Kees Rocks, PA 15136
412-788-4676    

male pharmacist

Rodney Alan Mell


Pharmacist
1800 Mckees Rocks Rd, Mc Kees Rocks, PA 15136
412-771-8366    

male pharmacist

Ronald Perry Ocvirk


Pharmacist
1770 Pine Hollow Rd, Mc Kees Rocks, PA 15136
412-331-7080     412-331-7187

female pharmacist

Mrs. Sandra L Trizzino, RPH


Pharmacist
7016 Pin Oak Ct, Mc Kees Rocks, PA 15136
412-641-4356     412-641-1104

female pharmacist

Sarah Schneider, PHARMD


Pharmacist
155 Chartiers Ave, Mc Kees Rocks, PA 15136
412-331-0106    

male pharmacist

Scott A Chieffo


Pharmacist
230 Field Club Cir, Mc Kees Rocks, PA 15136
412-874-6987    

male pharmacist

Zachary Weisser, PHARMD


Pharmacist
1800 Mckees Rocks Rd, Mc Kees Rocks, PA 15136
412-771-8366    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.